Browsing by Subject "Agonistic anti-CD40 mAb"
Now showing items 1-1 of 1
-
(2017-05-10)Lack of safe and effective adjuvants is a major hindrance to the development of efficacious vaccines. Signaling via CD40 pathway leads to enhanced antigen processing and presentation, nitric oxide expression, pro-inflammatory ...